T1	Participants 1093 1165	The results indicate a possible effect of tetrahydrobiopterin treatment.
T2	Participants 618 750	The results showed small nonsignificant changes in the total scores of Childhood Autism Rating Scale after 3- and 6-month treatment.
T3	Participants 125 401	Twelve children, all boys, aged 4 to 7 years, with a diagnosis of autistic disorder and low concentrations of spinal 6R-l-erythro-5,6,7,8-tetrahydrobiopterin (tetrahydrobiopterin) were selected to participate in a double-blind, randomized, placebo-controlled, crossover study.
T4	Participants 0 123	Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study.
